Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of US men: a prospective study.

Lu B, Wu Y, Nielson CM, Flores R, Abrahamsen M, Papenfuss M, Harris RB, Giuliano AR.

J Infect Dis. 2009 Feb 1;199(3):362-71. doi: 10.1086/596050.

PMID:
19133808
2.

Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students.

Partridge JM, Hughes JP, Feng Q, Winer RL, Weaver BA, Xi LF, Stern ME, Lee SK, O'Reilly SF, Hawes SE, Kiviat NB, Koutsky LA.

J Infect Dis. 2007 Oct 15;196(8):1128-36. Epub 2007 Sep 13.

PMID:
17955430
3.

Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men.

Giuliano AR, Lu B, Nielson CM, Flores R, Papenfuss MR, Lee JH, Abrahamsen M, Harris RB.

J Infect Dis. 2008 Sep 15;198(6):827-35. doi: 10.1086/591095.

PMID:
18657037
4.

HPV in female partners increases risk of incident HPV infection acquisition in heterosexual men in rural central Mexico.

Morales R, Parada R, Giuliano AR, Cruz A, Castellsagué X, Salmerón J, Lazcano-Ponce E.

Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):1956-65. doi: 10.1158/1055-9965.EPI-12-0470. Epub 2012 Aug 22.

5.

Acquisition of new infection and clearance of type-specific human papillomavirus infections in female students in Busan, South Korea: a follow-up study.

Oh JK, Ju YH, Franceschi S, Quint W, Shin HR.

BMC Infect Dis. 2008 Jan 30;8:13. doi: 10.1186/1471-2334-8-13.

6.

Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic.

Svare EI, Kjaer SK, Worm AM, Osterlind A, Meijer CJ, van den Brule AJ.

Sex Transm Infect. 2002 Jun;78(3):215-8.

7.

Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men.

Lajous M, Mueller N, Cruz-Valdéz A, Aguilar LV, Franceschi S, Hernández-Avila M, Lazcano-Ponce E.

Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1710-6.

8.

Correlates of the spread of human papillomavirus infection.

Silins I, Kallings I, Dillner J.

Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):953-9.

9.

Acquisition of anal human papillomavirus (HPV) infection in women: the Hawaii HPV Cohort study.

Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Ning L, Killeen J, Kamemoto L, Hernandez BY.

J Infect Dis. 2008 Apr 1;197(7):957-66. doi: 10.1086/529207.

PMID:
18429348
10.

Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study.

de Pokomandy A, Rouleau D, Ghattas G, Vézina S, Coté P, Macleod J, Allaire G, Franco EL, Coutlée F; HIPVIRG Study Group.

J Infect Dis. 2009 Apr 1;199(7):965-73. doi: 10.1086/597207.

PMID:
19239366
11.

Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe.

Fukuchi E, Sawaya GF, Chirenje M, Magure T, Tuveson J, Ma Y, Shiboski S, Da Costa M, Palefsky J, Moscicki AB, Makunike-Mutasa R, Chipato T, Smith-McCune KK.

Sex Transm Dis. 2009 May;36(5):305-11. doi: 10.1097/OLQ.0b013e318194eb76.

PMID:
19295468
12.

HPV 6/11, 16, 18 seroprevalence in men in two US cities.

Dunne EF, Nielson CM, Hagensee ME, Papenfuss MR, Harris RB, Herrel N, Gourlie J, Abrahamsen M, Markowitz LE, Giuliano AR.

Sex Transm Dis. 2009 Nov;36(11):671-4. doi: 10.1097/OLQ.0b013e3181bc094b.

PMID:
19809385
13.

Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys.

Vaccarella S, Franceschi S, Herrero R, Muñoz N, Snijders PJ, Clifford GM, Smith JS, Lazcano-Ponce E, Sukvirach S, Shin HR, de Sanjosé S, Molano M, Matos E, Ferreccio C, Anh PT, Thomas JO, Meijer CJ; IARC HPV Prevalence Surveys Study Group.

Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):326-33.

14.

Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States.

Thompson DL, Douglas JM Jr, Foster M, Hagensee ME, Diguiseppi C, Barón AE, Cameron JE, Spencer TC, Zenilman J, Malotte CK, Bolan G, Kamb ML, Peterman TA; Project RESPECT Study Group.

J Infect Dis. 2004 Nov 1;190(9):1563-74. Epub 2004 Sep 23.

PMID:
15478060
15.

Differences in factors associated with oncogenic and nononcogenic human papillomavirus infection at the United States-Mexico border.

Giuliano AR, Papenfuss M, Abrahamsen M, Inserra P.

Cancer Epidemiol Biomarkers Prev. 2002 Sep;11(9):930-4.

16.

Male circumcision and serologically determined human papillomavirus infection in a birth cohort.

Dickson NP, Ryding J, van Roode T, Paul C, Herbison P, Dillner J, Skegg DC.

Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):177-83. doi: 10.1158/1055-9965.EPI-08-0353.

17.

Risk factors for anogenital human papillomavirus infection in men.

Nielson CM, Harris RB, Dunne EF, Abrahamsen M, Papenfuss MR, Flores R, Markowitz LE, Giuliano AR.

J Infect Dis. 2007 Oct 15;196(8):1137-45. Epub 2007 Sep 17.

18.

Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers.

Kjaer SK, Munk C, Winther JF, Jørgensen HO, Meijer CJ, van den Brule AJ.

Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1528-33.

19.

Sexual behavior, human papillomavirus type 16 (HPV 16) infection, and HPV 16 seropositivity.

Castle PE, Shields T, Kirnbauer R, Manos MM, Burk RD, Glass AG, Scott DR, Sherman ME, Schiffman M.

Sex Transm Dis. 2002 Mar;29(3):182-7.

PMID:
11875380
20.

Prevalence of and risk factors for anal human papillomavirus infection in heterosexual men.

Nyitray A, Nielson CM, Harris RB, Flores R, Abrahamsen M, Dunne EF, Giuliano AR.

J Infect Dis. 2008 Jun 15;197(12):1676-84. doi: 10.1086/588145.

PMID:
18426367

Supplemental Content

Support Center